Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-31 4:15 pm Purchase |
2023-01-27 | 13D | Jasper Therapeutics, Inc. JSPR |
Carlyle Group Inc. CG |
876,189 8.000% |
313,333 (+55.67%) |
Filing History |
| 2023-01-30 5:01 pm Purchase |
2023-01-27 | 13G | Jasper Therapeutics, Inc. JSPR |
Soleus Capital Master Fund, L.P. | 625,000 5.700% |
625,000 (New Position) |
Filing History |
| 2023-01-27 4:56 pm Purchase |
2023-01-25 | 13G | Jasper Therapeutics, Inc. JSPR |
Velan Capital Investment Management LP | 1,121,904 10.200% |
1,121,904 (New Position) |
Filing History |
| 2022-08-11 4:47 pm Purchase |
2022-08-01 | 13D | Jasper Therapeutics, Inc. JSPR |
Carlyle Group Inc. CG |
562,856 15.400% |
562,856 (New Position) |
Filing History |
| 2022-04-28 4:25 pm Sale |
2022-04-12 | 13G | Jasper Therapeutics, Inc. JSPR |
Amplitude Healthcare Holdings LLC | 167,828 11.000% |
-82,172 (-32.87%) |
Filing History |
| 2022-02-14 10:29 am Unchanged |
2021-12-31 | 13G | Jasper Therapeutics, Inc. JSPR |
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-14 06:30 am Sale |
2021-12-31 | 13G | Jasper Therapeutics, Inc. JSPR |
Citadel Advisors LLC | 368,120 9.900% |
-186 (-0.05%) |
Filing History |
| 2022-02-11 5:02 pm Unchanged |
2021-12-31 | 13G | Jasper Therapeutics, Inc. JSPR |
Beryl Capital Management LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-03 1:56 pm Purchase |
2021-12-31 | 13G | Jasper Therapeutics, Inc. JSPR |
Tenor Capital Management Company, L.P. | 25,000 0.680% |
25,000 (New Position) |
Filing History |
| 2021-10-04 4:34 pm Purchase |
2020-09-24 | 13G | Jasper Therapeutics, Inc. JSPR |
Amplitude Healthcare Holdings LLC | 250,000 6.850% |
250,000 (New Position) |
Filing History |
| 2021-10-04 4:10 pm Purchase |
2021-09-24 | 13D | Jasper Therapeutics, Inc. JSPR |
Abingworth LLP | 562,856 15.400% |
562,856 (New Position) |
Filing History |
| 2021-10-04 4:02 pm Purchase |
2021-09-24 | 13G | Jasper Therapeutics, Inc. JSPR |
Citadel Advisors LLC | 368,306 9.900% |
368,306 (New Position) |
Filing History |
| 2021-10-04 3:56 pm Purchase |
2021-09-24 | 13G | Jasper Therapeutics, Inc. JSPR |
Avego Management LLC | 283,828 7.800% |
283,828 (New Position) |
Filing History |
| 2021-10-04 08:54 am Purchase |
2021-09-24 | 13G | Jasper Therapeutics, Inc. JSPR |
Roche Finance Ltd | 462,461 12.700% |
462,461 (New Position) |
Filing History |
| 2021-10-01 5:27 pm Purchase |
2021-09-24 | 13G | Jasper Therapeutics, Inc. JSPR |
AMGEN INC AMGN |
270,000 7.400% |
270,000 (New Position) |
Filing History |
| 2021-10-01 4:13 pm Purchase |
2021-09-24 | 13G | Jasper Therapeutics, Inc. JSPR |
Qiming U.S. Healthcare Fund II L.P. | 585,298 16.000% |
585,298 (New Position) |
Filing History |
| 2021-09-17 4:45 pm Purchase |
2021-09-07 | 13G | Amplitude Healthcare Acquisition Corporation AMHC |
Beryl Capital Management LLC | 647,206 6.500% |
647,206 (New Position) |
Filing History |
| 2021-07-12 12:52 pm Sale |
2021-06-30 | 13G | Amplitude Healthcare Acquisition Corporation AMHC |
Glazer Capital, LLC | 59,397 0.590% |
-1,013,728 (-94.47%) |
Filing History |
| 2021-02-16 4:35 pm Unchanged |
2020-12-31 | 13G | Amplitude Healthcare Acquisition Corporation AMHC |
Amplitude Healthcare Holdings LLC | 2,500,000 20.000% |
0 (Unchanged) |
Filing History |
| 2021-02-16 09:47 am Sale |
2020-12-31 | 13G | Amplitude Healthcare Acquisition Corporation AMHC |
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 500,000 5.000% |
-50,000 (-9.09%) |
Filing History |